Brief Overview of hyperlipidemia in primary care

A patient's lipid panel comes back, the LDL is elevated, and you have about ten minutes to decide whether this needs a statin, a recheck, or just lifestyle counseling. Here's how to make that call quickly and document it cleanly.

Dyslipidemia vs. hyperlipidemia: the terms

• Dyslipidemia is the broad term for abnormal cholesterol or lipid levels that raise cardiovascular risk. Medication may or may not be part of the plan.
• Hyperlipidemia is more specific. It means elevated total cholesterol, LDL, or triglycerides.

When to start screening

Recommendations vary by guideline. In general:

• Higher-risk patients (family history, metabolic syndrome, diabetes, smoking): start screening around age 20 to 30.
• Lower-risk patients: start around age 35 to 40.
• Men carry higher baseline risk, so earlier screening can be reasonable.

When to start a statin

The March 2026 ACC/AHA/multisociety dyslipidemia guideline reworked this part of the visit. It replaced the old Pooled Cohort Equations with the PREVENT-ASCVD risk equations, which run lower for a lot of patients, and it brought back explicit LDL-C and non-HDL-C treatment targets instead of a single statin-intensity bucket. The core "no debate" indications below haven't moved. The risk-based trigger has.

Start statin therapy if any of these are present:

• History of stroke or coronary heart disease
• LDL greater than or equal to 190 mg/dL
• LDL 160 mg/dL or higher, even without a calculated risk score. The 2026 guideline added this as a standalone trigger for statin consideration, the reasoning being that lifetime LDL exposure matters on its own, not just the 10-year number.
• Diabetes, CKD stage 3 to 4, or HIV, ages 40 to 75: current guidance leans toward treating this group regardless of LDL-C level, broader than the older "diabetes plus LDL 70 to 189" rule. Sourcing on the exact scope of this bullet wasn't fully consistent, so if you're building it into a note template as a hard rule, it's worth confirming the precise wording against the full guideline text first.
• LDL 70 to 189 mg/dL with an elevated 10-year ASCVD risk by PREVENT: intermediate (5% to under 10%) or high (10% or higher) risk.

PREVENT risk bands: low under 3%, borderline 3% to under 5%, intermediate 5% to under 10%, high 10% or higher. Most current EMRs and calculators have moved to PREVENT. If yours is still running the old Pooled Cohort Equations or the ASCVD Plus tool, don't try to eyeball a conversion, PREVENT tends to estimate lower risk for the same patient, so the numbers aren't directly comparable.

Which statin to pick

• First-line: atorvastatin 10 to 20 mg daily. Recheck labs in about 2 months and adjust.
• If statin side effects like muscle cramps: switch to rosuvastatin 5 to 10 mg daily.
• If statins aren't tolerated: consider ezetimibe 10 mg daily.

Intensity should match risk. High-intensity statins (atorvastatin 40 to 80 mg, rosuvastatin 20 to 40 mg) lower LDL more than 50%. Moderate intensity lowers it 30 to 49%. The 2026 guideline frames this as treating to an explicit LDL-C or non-HDL-C target rather than picking an intensity bucket and stopping, more on that in the starting a statin post. For more on side effects and alternatives, see statin intolerance.

Clinical pearls for busy NPs

• Coding matters. Medicare often won't cover a lipid panel billed purely as screening. Use hyperlipidemia or Z13.220 (screening for lipid disorders). An annual physical code can sometimes work too.
• Baseline labs. Check baseline liver function (AST/ALT) before starting a statin.
• Follow-up. Repeat the lipid panel 4 to 12 weeks after starting or changing a dose, then every 3 to 12 months.
• True statin allergy is rare. Many patients tolerate a different statin or a lower dose.
• Lifestyle still counts. Statins work best alongside diet, exercise, weight management, and smoking cessation.
• Don't undertreat. Patients with ASCVD, LDL greater than or equal to 190, or LDL 160 or higher almost always need a statin. Lifestyle alone won't get there.
• Diabetes. Nearly all adults 40 and older with diabetes should be on a statin unless contraindicated, and current guidance extends that same leaning to CKD 3-4 and HIV.

Frequently asked questions

Do I need a fasting lipid panel?
For most patients a non-fasting panel is fine for screening and risk decisions. Fasting helps when triglycerides are very high or you're tracking them specifically.

What if the patient refuses a statin?
Document the conversation, the indication, and the shared decision. Offer lifestyle changes, recheck the panel, and revisit the statin at follow-up. Some patients come around once they see the numbers move or not move.

How soon do I recheck after starting?
Recheck the lipid panel in about 4 to 12 weeks to see the response and confirm adherence, then space it out to every 3 to 12 months.

What's PREVENT, and is it the same as the Pooled Cohort Equations?
No. PREVENT is the newer risk calculator adopted by the March 2026 ACC/AHA dyslipidemia guideline. It tends to run lower than the Pooled Cohort Equations for the same patient and doesn't map cleanly onto the old 7.5% cut point, so a patient who was "intermediate risk" under the old tool isn't automatically the same category under PREVENT. Treat them as two different systems, not interchangeable versions of the same number.

Is the LDL 160 rule new?
Yes. The March 2026 guideline added it: LDL 160 mg/dL or higher can justify statin consideration on its own, without running a 10-year risk score first. It sits alongside, not instead of, the LDL 190 and risk-based triggers above.

Cholesterol management is one of the highest-yield things you do in primary care, and most of it comes down to a few clear decision points. Source: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia, Circulation, March 2026. For a one-page version you can keep open during a visit, the Clinical Desk Reference covers it. If you want the full workup, the Primary Care Clinical Mastery Program walks through lipid management start to finish. You can also read more on the coronary artery calcium test when risk is borderline.

Education only. Use clinical judgment and your local guidelines.

Written by Allison Sowders, MSN, APRN, FNP-BC, a practicing primary care nurse practitioner and founder of Nurse Practitioner Mentor. Reviewed September 2026.